ºÚÁϲ»´òìÈ

GOHAR ESLAMI, Pharm.D., Ph.D., is a clinical researcher/clinical trial operation and Molecular Tumor Board manager with Early Drug Development at the Stanford Cancer Institute. She has extensive expertise in drug development/discovery, precision medicine, early- and late-phase clinical trials, drug safety, and targeted therapies. She earned a doctorate in Pharmacotherapy, completing her pharmacogenomics training at the University of Florida. Previously she served as an assistant professor of pharmacy, where she was actively involved in training pharmacy students and residents, while providing inpatient and outpatient clinical pharmacy services. During this time, she also contributed to late-phase clinical trials and gained experience working within the pharmaceutical industry. She teaches courses in Drug Discovery and Translational Medicine, preparing students to bridge scientific innovation with clinical application.